Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
31.3M
-
Number of holders
-
224
-
Total 13F shares, excl. options
-
29.2M
-
Shares change
-
+468K
-
Total reported value, excl. options
-
$2.5B
-
Value change
-
+$41.1M
-
Put/Call ratio
-
0.28
-
Number of buys
-
115
-
Number of sells
-
-105
-
Price
-
$85.57
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q2 2019
261 filings reported holding CNMD - CONMED Corp - Common Stock as of Q2 2019.
CONMED Corp - Common Stock (CNMD) has 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.2M shares
of 31.3M outstanding shares and own 93.44% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.09M shares), VANGUARD GROUP INC (2.87M shares), Capital Research Global Investors (2.27M shares), Champlain Investment Partners, LLC (1.45M shares), DIMENSIONAL FUND ADVISORS LP (1.38M shares), STATE STREET CORP (1.02M shares), MACQUARIE GROUP LTD (794K shares), Point72 Asset Management, L.P. (740K shares), PRINCIPAL FINANCIAL GROUP INC (700K shares), and GOLDMAN SACHS GROUP INC (654K shares).
This table shows the top 224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.